Monday, August 11, 2025
  • REPORT A STORY
  • PRIVACY POLICY
  • CONTACT
WITHIN NIGERIA
  • HOME
  • FEATURES
  • NEWS
  • ENTERTAINMENT
  • FACT CHECK
  • MORE
    • VIDEOS
    • GIST
    • PIECE (ARTICLES)
No Result
View All Result
WITHIN NIGERIA
  • HOME
  • FEATURES
  • NEWS
  • ENTERTAINMENT
  • FACT CHECK
  • MORE
    • VIDEOS
    • GIST
    • PIECE (ARTICLES)
No Result
View All Result
WITHIN NIGERIA
No Result
View All Result
  • HOME
  • FEATURES
  • NEWS
  • ENTERTAINMENT
  • FACT CHECK
  • MORE

No approved herbal medicine to treat COVID-19, NAFDAC insists

by Adejayan Gbenga Gsong
July 11, 2020
in National
Reading Time: 2 mins read
A A
0
NAFDAC orders production of Chloroquine for the clinical trial treatment of Coronavirus
Share on FacebookShare on Twitter

The National Agency for Food and Drug Administration and Control (NAFDAC) on Friday insisted there is no approved herbal medicine to treat COVID-19, while debunking rumours that it has approved a certain herbal medicine – Pax Herbal, to treat COVID-19.

It described such news as wrong and inaccurate because it only listed and approved the product as ‘safe to use’ and not for its efficacy in treating COVID-19.

The agency said that although it is currently evaluating twenty-one (21) herbal medicines to determine how safe they are to consume, no herbal medicine in the country has been approved to treat COVID-19 associated symptoms because none have gone through clinical trials with humans.

The Director-General of NAFDAC, Prof. Mojisola Adeyeye, made this known in a statement in Abuja.

READ ALSO

Nigeria: How ADC’s Growing Strength Could Impact the 2027 Elections

Analysis: Understanding Nigeria’s New Unified Import Charge

Buhari’s Death, Unveiling of ADC: Major Incidents, Events That Shaped July 2025

TRIBUTE: Muhammadu Buhari, ex-Nigerian leader and the political king of North

Three Events Former President Buhari Will Be Remembered For As He Passes On

She said, “NAFDAC is currently processing twenty-one (21) herbal medicinal products for ‘safe to use’ or Listing status.

“Many of the applicants claim that their products are immune boosters and anti-infectives useful for relief of symptoms that could be associated with COVID-19.

“However, no clinical study has been done yet on any of the products to prove their claim of efficacy.

“Listing status involves the review of the composition of the formulation, the labelling of the product, the process of manufacture and “Safe to use” testing.

“Once the product is able to meet all requirements, a listing status is granted with a clear disclaimer that states clearly that claims have not been evaluated by NAFDAC.

“The applicant can arrange for clinical trials that will involve use of human subjects in order to prove efficacy or claim for treatment following laid down procedures and with the approval of NAFDAC. However, listing of a herbal product is not a requirement for the conduct of Clinical Trials.”

Adeyeye added, “Most of the applicants that submitted herbal medicines that are currently undergoing processing have been issued compliance directives to provide additional information or/and evidence of good manufacturing practice or environment fit for production of the medicines.

“Paxherbal applied for Listing of Pax Herbal Cugzin capsule 290mg which was approved by NAFDAC and Listed as ‘Safe to use’.

“The applicant claimed that it is an immune booster and an anti- infective. However, as part of the labelling of the product, and in line with global practice, a disclaimer is on the product label which clearly states that the claims have not been evaluated by NAFDAC.

“Therefore, the statements circulating in the social media that NAFDAC has approved Paxherbal product ‘specifically for treating symptoms associated with Coronavirus’ is wrong and inaccurate.

“Until a clinical study is done in a scientific manner, no herbal medicine manufacturer can claim effectiveness to treat COVID-19 associated symptoms.”

RELATED STORYPosts

Analysis

Nigeria: How ADC’s Growing Strength Could Impact the 2027 Elections

by Caleb Ijioma
August 11, 2025
Understanding Nigeria's New Unified Import Charge
Analysis

Analysis: Understanding Nigeria’s New Unified Import Charge

by Caleb Ijioma
August 11, 2025

Discussion about this post

JUST IN

Farotimi backs Obi’s one-term presidency pledge, says Obasanjo, Buhari wasted eight years

by TheOpeyemi A.A²
12:25 Aug 11, 2025

Obi has promised to serve only four years if elected in 2027…

WITHIN NIGERIA

WITHIN NIGERIA MEDIA LTD.

NEWS, MULTI MEDIA

WITHIN NIGERIA is an online news media that focuses on authoritative reports, investigations and major headlines that springs from National issues, Politics, Metro, Entertainment; and Articles.

Follow us on social media:

CORPORATE LINKS

  • About
  • Contacts
  • Report a story
  • Advertisement
  • Content Policy
  • Privacy Policy
  • Terms
 
  • Fact-Checking Policy
  • Ethics Policy
  • Corrections Policy
  • WHO IS WITHIN NIGERIA?
  • CONTACT US
  • PRIVACY
  • TERMS

© 2022 WITHIN NIGERIA MEDIA LTD. designed by WebAndName

No Result
View All Result
  • HOME
  • FEATURES
  • NEWS
  • ENTERTAINMENT
  • FACT CHECK
  • MORE
    • VIDEOS
    • GIST
    • PIECE (ARTICLES)

© 2022 WITHIN NIGERIA MEDIA LTD. designed by WebAndName